XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.0.1
STOCKHOLDERS’ EQUITY (Tables)
6 Months Ended
Dec. 31, 2021
Equity [Abstract]  
SCHEDULE OF STOCK WARRANT ACTIVITY

Warrant detail for the six months ended December 31, 2021 is reflected below:

 

   Number of Warrants   Weighted Average Exercise Price Per Warrant   Remaining Contract Term (# years) 
Warrants outstanding and exercisable at June 30, 2021   214,883   $4.49    2.92 
Warrants issued   1,071,430   $7.00    5.00 
Warrants outstanding and exercisable at December 31, 2021   1,286,313   $6.58    4.35 

 

Warrant detail for the six months ended December 31, 2020 is reflected below:

 

   Number of Warrants   Weighted Average Exercise Price Per Warrant   Remaining Contract Term (# years) 
Warrants outstanding and exercisable at June 30, 2020   83,205   $4.00    2.01 
Warrants issued   185,955   $4.80    5.00 
Warrants outstanding at December 31, 2020   269,160   $4.55    3.66 
Warrants exercisable at December 31, 2020   83,205   $4.00    1.50 
SCHEDULE OF STOCK OPTIONS ACTIVITY

Activity in the Company’s stock options during the six months ended December 31, 2021 and related balances outstanding as of that date are reflected below:

 

   Number of Shares   Weighted Average Exercise Price  

Weighted Average Remaining Contract Term

(# years)

 
Outstanding at June 30, 2021   531,205   $11.02    6.73 
Granted   -   $-    - 
Exercised   (3,400)  $4.65    - 
Forfeited and cancelled   (14,199)  $13.70    - 
Outstanding at December 31, 2021   513,606   $10.99    6.20 
Exercisable at December 31, 2021   500,623   $10.95    6.16 

 

Activity in the Company’s stock options during the six months ended December 31, 2020 and related balances outstanding as of that date are reflected below:

 

   Number of Shares   Weighted Average Exercise Price  

Weighted Average Remaining Contract Term

(# years)

 
Outstanding at June 30, 2020   579,584   $11.00    7.55 
Granted   -   $-    - 
Exercised   (10,750)  $4.60    - 
Forfeited and cancelled   (7,463)  $7.31    - 
Outstanding at December 31, 2020   561,371   $11.17    6.87 
Exercisable at December 31, 2020   493,224   $10.94    6.67 
SCHEDULE OF RESTRICTED STOCK UNITS ACTIVITY

Activity in RSUs during the six months ended December 31, 2021 and related balances outstanding as of that date are reflected below:

 

   Number of Shares   Weighted Average Grant date Fair Value  

Weighted Average Remaining Contract Term

(# years)

 
Outstanding at June 30, 2021   131,652   $9.25    2.72 
Granted   179,614   $5.75    - 
Forfeited and cancelled   (18,334)  $7.71    - 
Outstanding at December 31, 2021   292,932   $7.22    2.69 

 

 

Activity in RSUs during the six months ended December 31, 2020 and related balances outstanding as of that date are reflected below:

 

   Number of Shares   Weighted Average Grant date Fair Value  

Weighted Average Remaining Contract Term

(# years)

 
Outstanding at June 30, 2020   -   $-    - 
Granted   134,865   $8.88    - 
Forfeited and cancelled   (4,228)  $8.88    - 
Outstanding at December 31, 2020   130,637   $8.88    3.15 
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSES

The following table summarizes stock-based compensation expense for employee and non-employee stock option and RSU grants:

 

  

Three Months Ended
December 31,

  

Six Months Ended
December 31,

 
   2021   2020   2021   2020 
Research and development  $54,000   $45,000   $90,000   $98,000 
Selling and administrative   195,000    152,000    359,000    324,000 
Total stock-based compensation expense  $249,000   $197,000   $449,000   $422,000